ArticleBMC neurology2026

Responder discordance between migraine frequency and patient-reported outcomes after CGRP-pathway monoclonal antibody treatment: a secondary analysis of public patient-level data.

Chuntao Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.